User:Mr. Ibrahem/Isavuconazonium

Isavuconazonium, sold under the brand name Cresemba, is a medication used to treat invasive aspergillosis and mucormycosis. For mucormycosis, it is used when amphotericin B is not suitable. It may be taken by mouth or given by gradual injection into a vein.

Common side effects include liver problems, nausea, shortness of breath, abdominal pain, diarrhea, headache, low potassium and rash. Other side effects may include anaphylaxis and short QT. Use in pregnancy may harm the baby. It is a antifungal medication of the triazole class and works after being converted into isavuconazole in the body.

Isavuconazonium was approved for medical use in the United States and Europe in 2015. In the United Kingdom a vial of 200 mg cost the NHS about £300 as of 2021. This amount in the United States costs about 350 USD.